While the accumulation of CCND2 is the most common disease mechanism associated with CCND2-associated disorders, a number of cancers have been found to have reduced CCND2 due to CCND2 hypermethylation, particularly breast and lung cancers [89]. This evidence concerns the gene CCND2 and lung cancer.